Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.


ratings:
Length:
11 minutes
Released:
Mar 17, 2022
Format:
Podcast episode

Description

On this episode I discuss roflumilast (Daliresp) pharmacology, adverse effects, and important drug interactions.



Roflumilast is indicated to reduce the incidence of COPD exacerbations.



Roflumilast is significantly broken down by CYP3A4 so there are numerous drug interactions that we have to take into account.



Psychiatric issues, GI upset, and weight loss are all potential adverse effects due to roflumilast.
Released:
Mar 17, 2022
Format:
Podcast episode

Titles in the series (100)

A Meded101.com Production